Clinical trials
Completed Bronchiolitis Obliterans Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
383 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 9 |
| 2004 | 9 |
| 2005 | 14 |
| 2006 | 15 |
| 2007 | 16 |
| 2008 | 21 |
| 2009 | 17 |
| 2010 | 24 |
| 2011 | 23 |
| 2012 | 24 |
| 2013 | 16 |
| 2014 | 19 |
| 2015 | 35 |
| 2016 | 20 |
| 2017 | 22 |
| 2018 | 15 |
| 2019 | 11 |
| 2020 | 11 |
| 2021 | 11 |
| 2022 | 9 |
| 2023 | 14 |
| 2024 | 13 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 383 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 13 |
| Hoffmann-La Roche | 11 |
| AstraZeneca | 8 |
| Pfizer | 7 |
| Gilead Sciences | 6 |
| Dana-Farber Cancer Institute | 5 |
| National Cancer Institute (NCI) | 5 |
| Pharmacyclics LLC. | 5 |
| Celgene | 4 |
| Foundation for Liver Research | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiolitis Obliterans Syndrome | 383 |
| Pain | 28 |
| Leukemia | 26 |
| Low Back Pain | 26 |
| Graft vs Host Disease | 23 |
| Hepatitis C | 19 |
| Lymphoma, Follicular | 15 |
| Pulmonary Disease, Chronic Obstructive | 14 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 13 |
| Stroke | 13 |
Trials
Showing 1 to 25 of 383. Each trial links to its page on Pharma Observatory.
283 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.